InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,224.21
(
0.05%
)
US TECH 100
17,739.60
(
0.09%
)
Dow Jones
39,481.37
(
0.13%
)
Brent Oil
82.90
(
-0.38%
)
Bitcoin
61,653.73
(
-1.99%
)
Post# of 22815
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

pivotpoint1

Send PM Follow Ignore
Followers 281
Posts 59167
Boards Moderated 0
Alias Born 02/15/2012

pivotpoint1

Re: None

Thursday, 01/26/2017 1:22:24 PM

Thursday, January 26, 2017 1:22:24 PM

Post# of 22815
$BKIT ~ The company is about to move into a phase 2 trial investigating the efficacy and tolerability of ZLX-1 in patients suffering from stress-induced insomnia, and this trial should complete by late this year, or early 2018 at the latest. Beyond that comes a pivotal trial or (and this is optimistic, but very realistic) a partnership with big pharma, and the taking over of development of the drug by the acquirer.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up